Frank Takkinen
Stock Analyst at Lake Street
(1.01)
# 3,922
Out of 5,113 analysts
73
Total ratings
28.79%
Success rate
-12.55%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCEL AVITA Medical | Maintains: Hold | $3 → $3.5 | $4.57 | -23.41% | 2 | Jan 16, 2026 | |
| BBNX Beta Bionics | Maintains: Buy | $35 → $40 | $14.93 | +167.92% | 2 | Jan 9, 2026 | |
| KRMD KORU Medical Systems | Maintains: Buy | $6 → $8 | $5.68 | +40.85% | 3 | Dec 22, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $7 → $12 | $6.02 | +99.34% | 7 | Dec 10, 2025 | |
| AXGN Axogen | Maintains: Buy | $30 → $40 | $34.59 | +15.64% | 2 | Dec 4, 2025 | |
| NOTV Inotiv | Maintains: Buy | $5 → $3 | $0.53 | +470.02% | 8 | Dec 4, 2025 | |
| ADGM Adagio Medical Holdings | Initiates: Buy | $4 | $1.00 | +300.00% | 1 | Dec 2, 2025 | |
| TELA TELA Bio | Maintains: Buy | $6 → $3 | $0.98 | +206.12% | 3 | Dec 1, 2025 | |
| LUNG Pulmonx | Maintains: Buy | $8 → $4 | $1.75 | +128.57% | 3 | Oct 28, 2025 | |
| ELUT Elutia | Maintains: Buy | $8 → $6 | $1.00 | +500.00% | 4 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1.5 → $2 | $1.31 | +52.67% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $150 | $81.79 | +83.40% | 2 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $10.23 | +134.60% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $14 | $7.54 | +85.68% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $15 | $12.48 | +20.19% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $26 | $16.59 | +56.72% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $14.39 | +108.48% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $6.31 | +216.96% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.65 | +203.03% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $41.48 | -27.68% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $0.67 | +796.59% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.53 | +58.10% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $15.95 | -24.76% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $4.19 | +114.80% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $4.15 | +285.54% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $923 → $277 | $8.65 | +3,101.16% | 2 | Jan 18, 2023 |
AVITA Medical
Jan 16, 2026
Maintains: Hold
Price Target: $3 → $3.5
Current: $4.57
Upside: -23.41%
Beta Bionics
Jan 9, 2026
Maintains: Buy
Price Target: $35 → $40
Current: $14.93
Upside: +167.92%
KORU Medical Systems
Dec 22, 2025
Maintains: Buy
Price Target: $6 → $8
Current: $5.68
Upside: +40.85%
Sight Sciences
Dec 10, 2025
Maintains: Buy
Price Target: $7 → $12
Current: $6.02
Upside: +99.34%
Axogen
Dec 4, 2025
Maintains: Buy
Price Target: $30 → $40
Current: $34.59
Upside: +15.64%
Inotiv
Dec 4, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $0.53
Upside: +470.02%
Adagio Medical Holdings
Dec 2, 2025
Initiates: Buy
Price Target: $4
Current: $1.00
Upside: +300.00%
TELA Bio
Dec 1, 2025
Maintains: Buy
Price Target: $6 → $3
Current: $0.98
Upside: +206.12%
Pulmonx
Oct 28, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.75
Upside: +128.57%
Elutia
Sep 10, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $1.00
Upside: +500.00%
Aug 14, 2025
Maintains: Buy
Price Target: $1.5 → $2
Current: $1.31
Upside: +52.67%
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $150
Current: $81.79
Upside: +83.40%
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $10.23
Upside: +134.60%
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $7.54
Upside: +85.68%
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $12.48
Upside: +20.19%
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $16.59
Upside: +56.72%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $14.39
Upside: +108.48%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $6.31
Upside: +216.96%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $1.65
Upside: +203.03%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $41.48
Upside: -27.68%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $0.67
Upside: +796.59%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.53
Upside: +58.10%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $15.95
Upside: -24.76%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $4.19
Upside: +114.80%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $4.15
Upside: +285.54%
Jan 18, 2023
Maintains: Buy
Price Target: $923 → $277
Current: $8.65
Upside: +3,101.16%